Description
Description: Glenza contains Enzalutamide, a tyrosine kinase inhibitor used for cancer treatment.
Contents: Enzalutamide 80mg , 160mg
Uses:
- Treatment of differentiated thyroid cancer.
- Treatment of renal cell carcinoma in combination with everolimus.
How it Works: Inhibits multiple receptor tyrosine kinases involved in tumor growth and angiogenesis.
Directions for Use: Taken orally once daily, with or without food.
Side Effects:
- Hypertension
- Fatigue
- Diarrhea
- Nausea
Precautions:
- Monitor blood pressure regularly.
- Use with caution in patients with liver impairment.
There are no reviews yet.